logo
Select company
Select metric
-6.63%EBITDA Margin
VS
Market
24
Sector
58
Industry
80
History
57
$ 34.69Close
$ 18.76 - $ 39.72 52-Week Range
Ticker Information

Ticker

XOMA

Company Name

XOMA ROYALTY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XOMA ROYALTY CORP - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XOMA - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -2.98M-6.63%$ 44.95M
3/31/2025$ 3.33M7.75%$ 42.91M
12/31/2024$ -10.84M-38.03%$ 28.49M
9/30/2024$ -20.03M-92.72%$ 21.61M
6/30/2024$ -10.2M-66.94%$ 15.24M
3/31/2024$ -34.73M-597.68%$ 5.81M
12/31/2023$ -39.24M-824.78%$ 4.76M
9/30/2023$ -25.78M-584.52%$ 4.41M
6/30/2023$ -24.65M-611.28%$ 4.03M
3/31/2023$ -24.15M-719.36%$ 3.36M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XOMA ROYALTY CORP's latest trailing twelve months (TTM) EBITDA % stands at -491.74%.
  • Over the past 5 years, XOMA ROYALTY CORP's average EBITDA % has been -197.47%.
  • The median EBITDA % for XOMA ROYALTY CORP during this period was -22.33%
  • XOMA ROYALTY CORP reached its highest EBITDA % over the past 5 years at 52.15%.
  • The lowest EBITDA % recorded by XOMA ROYALTY CORP in the same timeframe -824.78%

XOMA ROYALTY CORP's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
SCPH : SCPHARMACEUTICALS INC -170.95%LXRX : LEXICON PHARMACEUTICALS INC -183.88%GOSS : GOSSAMER BIO INC -319.59%CDXS : CODEXIS INC -80.63%EDIT : EDITAS MEDICINE INC -605.19%FENC : FENNEC PHARMACEUTICALS INC -27.6%AQST : AQUESTIVE THERAPEUTICS INC -107.62%FHTX : FOGHORN THERAPEUTICS INC -274.86%SPRO : SPERO THERAPEUTICS INC -110.34%CELU : CELULARITY INC -130.41%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for XOMA ROYALTY CORP is calculated as follows: EBITDA [ $ -10.95M ] / Revenues [ $ 2.23M ]
(=) EBITDA % [ -491.74% ]

XOMA - EBITDA Margin, Last 5 years

-824.78%

Minimum

Dec 31, 2023

52.15%

Maximum

Mar 31, 2022

-197.47%

Average

-22.33%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%